HER2 Support Group Forums - View Single Post - Study suggests a new way to personalize anti-CTLA-4 therapy for cancers

News · 02-15-2021, 08:24 PM

A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors.

More...

02-15-2021, 08:24 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,959	Study suggests a new way to personalize anti-CTLA-4 therapy for cancers A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors. More...